RYLL DENNIS L 4
4 · ACCENTIA BIOPHARMACEUTICALS INC · Filed Jun 23, 2006
Insider Transaction Report
Form 4
RYLL DENNIS L
Director
Transactions
- Other
Common Stock
2006-04-03$8.00/sh+5,339$42,712→ 3,634,160 total(indirect: By MOAB Investment, LP.) - Other
Common Stock
2006-04-03$8.00/sh+252$2,016→ 34,414 total
Footnotes (2)
- [F1]Represents the receipt of shares of common stock in lieu of accrued but unpaid dividends on the Company's former Series E Convertible Preferred Stock at a price of $8.00 a share.
- [F2]Mr. Ryll is a limited partner in the MOAB Investment LP. Mr. Ryll disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.